Connect Biopharma (CNTB) Short Interest Ratio & Short Volume

$1.25

-0.06 (-4.58%)

(As of 07/26/2024 ET)

Compare

Connect Biopharma Short Interest Data

Current Short Interest: 10,800 shares
Previous Short Interest: 15,500 shares
Change Vs. Previous Month: -30.32%
Dollar Volume Sold Short: $13,608.00
Short Interest Ratio: 0.2 Days to Cover
Last Record Date: July 15, 2024

Outstanding Shares: 55,100,000 shares
Float Size: 53,110,000 shares
Short Percent of Float: 0.02%
Today's Trading Volume: 20,539 shares
Average Trading Volume: 110,811 shares
Today's Volume Vs. Average: 19%

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Selling Connect Biopharma ?

Sign up to receive the latest short interest report for Connect Biopharma and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

CNTB Short Interest Over Time

CNTB Days to Cover Over Time

CNTB Percentage of Float Shorted Over Time

Ad The Oxford Club

Don't Pay a Dime for Marc Lichtenfeld's Top AI Picks

Usually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research... But today, the author of Get Rich with Dividends is feeling extra generous...

Click here now to claim your FREE copy of Marc's AI playbook.

Connect Biopharma Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
7/15/2024	10,800 shares	$13,608.00	-30.3%	0.0%	0.2	$1.26
6/30/2024	15,500 shares	$23,560.00	-44.2%	0.0%	0.2	$1.52
6/15/2024	27,800 shares	$44,480.00	-21.5%	0.1%	0.2	$1.60
5/31/2024	35,400 shares	$60,534.00	-34.6%	0.1%	0.3	$1.71
5/15/2024	54,100 shares	$99,003.00	+73.4%	0.1%	0.3	$1.83
4/30/2024	31,200 shares	$43,368.00	-62.5%	0.1%	0.2	$1.39
Get the Latest News and Ratings for CNTB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter.
4/15/2024	83,100 shares	$138,777.00	-28.1%	0.2%	0.5	$1.67
3/31/2024	115,500 shares	$200,970.00	+7.5%	0.2%	0.7	$1.74
3/15/2024	107,400 shares	$139,620.00	-13.2%	0.2%	0.8	$1.30
2/29/2024	123,700 shares	$141,018.00	-2.7%	0.2%	0.4	$1.14
2/15/2024	127,100 shares	$153,791.00	-34.8%	0.2%	0.4	$1.21
1/31/2024	194,800 shares	$227,916.00	+52.8%	0.4%	0.5	$1.17
1/15/2024	127,500 shares	$140,862.00	-21.3%	0.2%	0.3	$1.10
12/31/2023	162,100 shares	$191,278.00	-59.8%	0.3%	0.4	$1.18
12/15/2023	403,200 shares	$380,540.16	+208.3%	0.8%	1.1	$0.94
11/30/2023	130,800 shares	$150,420.00	+476.2%	0.3%	0.6	$1.15
11/15/2023	22,700 shares	$40,406.00	-22.8%	0.0%	0.1	$1.78
10/31/2023	29,400 shares	$43,218.00	+88.5%	0.1%	0.5	$1.47
10/15/2023	15,600 shares	$13,543.92	-40.7%	0.0%	0.3	$0.87
9/30/2023	26,300 shares	$21,539.70	+250.7%	0.1%	0.6	$0.82
9/15/2023	7,500 shares	$5,700.75	-13.8%	0.0%	0.2	$0.76
8/31/2023	8,700 shares	$7,184.46	-61.5%	0.0%	0.2	$0.83
8/15/2023	22,600 shares	$20,358.08	-48.3%	0.0%	0.1	$0.90
7/31/2023	43,700 shares	$42,389.00	+55.5%	0.1%	0.1	$0.97
7/15/2023	28,100 shares	$30,348.00	-52.5%	0.1%	0.1	$1.08
6/30/2023	59,200 shares	$66,896.00	-19.8%	0.1%	0.2	$1.13
6/15/2023	73,800 shares	$74,538.00	-12.3%	0.1%	0.2	$1.01
5/31/2023	84,100 shares	$91,147.58	+14.3%	0.2%	0.1	$1.08
5/15/2023	73,600 shares	$91,256.64	-23.1%	0.1%	0.2	$1.24
4/30/2023	95,700 shares	$101,920.50	-25.8%	0.2%	0.3	$1.07
4/15/2023	128,900 shares	$135,345.00	-14.1%	0.2%	0.4	$1.05
3/31/2023	150,000 shares	$149,985.00	+100.8%	0.3%	0.5	$1.00
3/15/2023	74,700 shares	$83,664.00	-12.2%	0.1%	0.2	$1.12
2/28/2023	85,100 shares	$109,779.00	-15.0%	0.2%	1.6	$1.29
2/15/2023	100,100 shares	$103,103.00	-11.0%	0.2%	2	$1.03
1/31/2023	112,500 shares	$138,375.00	-3.5%	0.2%	2.3	$1.23
1/15/2023	116,600 shares	$115,317.40	-12.5%	0.2%	2.3	$0.99
12/30/2022	133,200 shares	$115,590.96	-58.0%	0.3%	2.4	$0.87
12/15/2022	316,800 shares	$275,616.00	-1.2%	0.6%	2.8	$0.87
11/30/2022	320,600 shares	$232,531.18	-4.0%	0.6%	2.8	$0.73
Get out of cash before the Fed's next meeting (Ad) "How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains." Click here now to watch this exclusive interview
11/15/2022	334,000 shares	$251,201.40	-8.2%	0.6%	2.5	$0.75
10/31/2022	364,000 shares	$316,607.20	-32.0%	0.7%	2.1	$0.87
10/15/2022	535,000 shares	$506,003.00	+29.9%	1.0%	1.7	$0.95
9/30/2022	411,900 shares	$531,351.00	+2.6%	0.8%	1.3	$1.29
9/15/2022	401,400 shares	$586,044.00	-15.7%	0.8%	1.1	$1.46
8/31/2022	476,400 shares	$666,960.00	-2.2%	0.9%	1.2	$1.40
8/15/2022	487,100 shares	$706,295.00	+1.1%	0.9%	1.2	$1.45
7/31/2022	481,600 shares	$392,600.32	+7.6%	0.9%	1.1	$0.82
7/15/2022	447,600 shares	$407,316.00	+124.8%	0.8%	1.1	$0.91
6/30/2022	199,100 shares	$173,217.00	+7.4%	0.4%	0.5	$0.87
6/15/2022	185,400 shares	$133,988.58	-18.0%	0.4%	0.7	$0.72
5/31/2022	226,000 shares	$180,800.00	+23.4%	N/A	0.9	$0.80
5/15/2022	183,100 shares	$137,325.00	-42.5%	N/A	0.7	$0.75
4/30/2022	318,400 shares	$646,352.00	+5.5%	N/A	1.7	$2.03
4/15/2022	301,900 shares	$863,434.00	+6.0%	N/A	3.5	$2.86
3/31/2022	284,900 shares	$860,398.00	+8.6%	N/A	2.3	$3.02
3/15/2022	262,400 shares	$645,504.00	+2.3%	N/A	1.1	$2.46
2/28/2022	256,500 shares	$1.01 million	+7.1%	N/A	0.9	$3.92
2/15/2022	239,600 shares	$1.08 million	-24.3%	N/A	0.7	$4.50
1/31/2022	316,600 shares	$1.46 million	-7.5%	0.6%	0.7	$4.60
1/15/2022	342,400 shares	$1.76 million	+25.7%	N/A	0.7	$5.14
12/31/2021	272,400 shares	$1.40 million	+3.6%	N/A	0.6	$5.15
12/15/2021	263,000 shares	$1.22 million	+533.7%	N/A	0.8	$4.64
11/30/2021	41,500 shares	$180,525.00	-97.7%	N/A	0.1	$4.35
11/15/2021	1,810,000 shares	$23.57 million	+30.2%	N/A	7.4	$13.02
10/29/2021	1,390,000 shares	$22.02 million	+36.3%	N/A	15.3	$15.84
10/15/2021	1,020,000 shares	$17.51 million	+19.3%	N/A	13.9	$17.17
9/30/2021	855,200 shares	$20.72 million	+0.1%	N/A	15.6	$24.23
9/15/2021	854,600 shares	$18.23 million	+0.3%	N/A	14.2	$21.33
8/31/2021	851,700 shares	$19.99 million	+0.6%	N/A	13.6	$23.47
8/13/2021	846,300 shares	$19.90 million	No Change	N/A	14.1	$23.51

CNTB Short Interest - Frequently Asked Questions

What is Connect Biopharma's current short interest?: Short interest is the volume of Connect Biopharma shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 10,800 shares of CNTB short. 0.02% of Connect Biopharma's shares are currently sold short. Learn More on Connect Biopharma's current short interest.
Which institutional investors are shorting Connect Biopharma?: As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Connect Biopharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.
What is a good short interest percentage for Connect Biopharma?: Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Connect Biopharma's floating shares are currently sold short.
Is Connect Biopharma's short interest increasing or decreasing?: Connect Biopharma saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 10,800 shares, a decline of 30.3% from the previous total of 15,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
What is Connect Biopharma's float size?: Connect Biopharma currently has issued a total of 55,100,000 shares. Some of Connect Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Connect Biopharma currently has a public float of 53,110,000 shares.

How does Connect Biopharma's short interest compare to its competitors?: 0.02% of Connect Biopharma's shares are currently sold short. Here is how the short interest of companies compare to Connect Biopharma: RAPT Therapeutics, Inc. (10.40%), Zentalis Pharmaceuticals, Inc. (14.67%), Nektar Therapeutics (5.44%), CorMedix Inc. (18.85%), Zevra Therapeutics, Inc. (7.63%), Foghorn Therapeutics Inc. (4.01%), Atai Life Sciences (7.95%), Nanobiotix S.A. (0.11%), Mersana Therapeutics, Inc. (7.82%), Gossamer Bio, Inc. (4.06%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.
What does it mean to sell short Connect Biopharma stock?: Short selling CNTB is an investing strategy that aims to generate trading profit from Connect Biopharma as its price is falling. CNTB shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Connect Biopharma?: A short squeeze for Connect Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNTB, which in turn drives the price of the stock up even further.
How often is Connect Biopharma's short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNTB, twice per month. The most recent reporting period available is July, 15 2024.